Physician profile
Arjun Patel
NPI 1730740473
$6,105.64
in general payments reported to CMS, 2019-2025
15 companies · $815 in 2025
The $815 reported for 2025 was more than what 94% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.79 · 2023: $523 · 2024: $4,748 · 2025: $815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,965 · Food and Beverage: $1,556 · Education: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,965.00 |
| Food and Beverage | $1,556.18 |
| Education | $565.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uoc USA INC | $3,988.58 | 2024 | U-Motion III, Psa, Locking Cage and Ustar II |
| Kestra Medical Technology Services, INC. | $594.26 | 2023-2025 | Assure Wcd |
| Abbott Laboratories | $475.43 | 2023-2024 | Ensite, Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $325.12 | 2023-2025 | Lifevest |
| Amgen INC. | $179.80 | 2025 | Repatha |
| Siemens Medical Solutions USA, INC. | $177.20 | 2024 | Naeotom Alpha, Artis Icono Floor |
| Janssen Biotech, INC. | $100.14 | 2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $88.33 | 2024 | |
| Abiomed | $42.75 | 2024 | Impella |
| Pfizer INC. | $35.56 | 2025 | |
| Teleflex LLC | $23.74 | 2025 | Turnpike |
| Medtronic, INC. | $19.35 | 2023 | Azure Xt Dr Mri Surescan |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.79 | 2019 | |
| Alnylam Pharmaceuticals INC. | $18.74 | 2025 | Onpattro |
| Merck Sharp & Dohme LLC | $17.85 | 2025 | Capvaxive, Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjun Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.